StockData

Nika Pharmaceuticals, Inc (NIKA) stock

NIKAOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 0/30
$0.41+0.00 (0.00%)

Close on Oct 16, 2026Market cap $431.19MP/E –Yield –

Nika Pharmaceuticals operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Nika Pharmaceuticals's operating cash flow for the twelve months ending Jun 30, 2026 was -$69.14K. For fiscal 2025 it was -$79.65K. The highest annual figure on record is $33.72K in fiscal 2022.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$79.65K–
FY2024Dec 31, 2024-$154.93K–
FY2023Dec 31, 2023-$64.83K-292.3%
FY2022Dec 31, 2022$33.72K+129.2%
FY2021Dec 31, 2021$14.71K–
FY2020Dec 31, 2020-$8.91K–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$7.60K–
Q1 FY2026Mar 31, 2026-$13.36K–
Q4 FY2025Dec 31, 2025-$38.86K–
Q3 FY2025Sep 30, 2025-$9.33K–
Q2 FY2025Jun 30, 2025-$18.52K–
Q1 FY2025Mar 31, 2025-$12.95K–
Q4 FY2024Dec 31, 2024-$28.30K–
Q1 FY2024Mar 31, 2024-$84.35K–
Q4 FY2023Dec 31, 2023-$7.31K-148.6%
Q3 FY2023Sep 30, 2023-$10.14K-229.4%
Q2 FY2023Jun 30, 2023-$27.81K-262.2%
Q1 FY2023Mar 31, 2023-$19.57K–
Q4 FY2022Dec 31, 2022$15.05K-42.4%
Q3 FY2022Sep 30, 2022$7.84K–
Q2 FY2022Jun 30, 2022$17.14K–
Q1 FY2022Mar 31, 2022-$6.32K–
Q4 FY2021Dec 31, 2021$26.12K–
Q3 FY2021Sep 30, 2021-$2.70K–
Q2 FY2021Jun 30, 2021-$2.96K–
Q1 FY2021Mar 31, 2021-$5.75K–
Q4 FY2020Dec 31, 2020-$5.75K–

More Nika Pharmaceuticals figures

See a number that looks wrong?